Evaluation of the Efficacy of Different Nebulization Techniques

Status Recruiting

Clinical Trial Summary

COPD is the 3rd most common cause of death in the world, and the most common places of admission in our country with exacerbation of COPD are emergency services. β-2 agonists and/or short-acting anticholinergic drugs use is recommended in patients with COPD Salbutamol is known to cause significant improvement in dyspnea, quality of life and FEV1 in patients with COPD. Various techniques are used to administer drugs, one of which is the nebulization technique and is frequently used in emergency departments. There are limited clinical studies comparing different nebulization techniques, and the aim of this study is to compare the efficacy of Vibrating MESH nebulizer versus Jet nebulizers in a COPD exacerbation patient. Patients who applied to the Emergency Department of Sultan Abdulhamid Han Training and Research Hospital with the complaint of shortness of breath and were diagnosed with COPD exacerbation according to the Gold Guidelines and to be treated with nebulization will be included in the study. Patients who agreed to participate in the study will be divided into two groups and assigned sequentially according to the simple randomization schedule. Medication will be applied to one group with Jet nebulizers (Philips Respironics) and to the other group with Vibrating MESH nebulizer (Aerogen Ultra). Vital signs, IPI, spirometric measurements (FEV 1, FVC, FEV1 / FVC, FEF 50, FEF 2575), and dyspnea VAS score will be recorded at admission and re-measured after 1hour of treatment . In addition, single dose nebulization time will be measured and patient satisfaction will be measured with a 5-linkert scale. Demographic data will be recorded. The measurements will be recorded in the patient file and the groups will be coded so that the researcher evaluating the data will be blinded to the groups. The patient could not be blinded because of the different shape of devices.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

COPD Exacerbation

Clinical Trial Details

NCT number	NCT05507060
Study type	Interventional
Source	Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Contact	Erdem Cevik, MD
Phone	+905054515930
Email	cevikerdem@yahoo.com
Status	Recruiting
Phase	N/A
Start date	August 1, 2022
Completion date	September 25, 2022

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06000696` - Healthy at Home Pilot
Recruiting	`NCT03250000` - Changes in Microcirculation and Functional Status During Exacerbation of COPD	N/A
Recruiting	`NCT04142827` - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)	N/A
Recruiting	`NCT05865184` - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed	`NCT01892566` - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV	N/A
Completed	`NCT04119856` - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD	N/A
Recruiting	`NCT06118632` - Physiological and Environmental Data in a Remote Setting to Predict Exacerbation Events in Patients With Chronic Obstructive Pulmonary Disease
Recruiting	`NCT04860375` - Multidisciplinary Management of Severe COPD	N/A
Completed	`NCT04170361` - The Effect of Incentive Spirometry Added to Routine Physiotherapy Program on Hemodynamic Responses and Hospital Stay in Patients With COPD Exacerbation	N/A
Not yet recruiting	`NCT03696563` - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS	N/A
Not yet recruiting	`NCT03296215` - Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals	N/A
Completed	`NCT02912689` - NIV - NAVA vs NIV - PS for COPD Exacerbation	N/A
Completed	`NCT03003702` - Domiciliary Monitoring to Predict Exacerbations of COPD	N/A
Recruiting	`NCT02264483` - Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile.	N/A
Completed	`NCT01443845` - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)	Phase 4
Recruiting	`NCT02065921` - Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort
Completed	`NCT04880486` - Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease	N/A
Recruiting	`NCT03286127` - Palliative Outcome Evaluation Muenster I
Recruiting	`NCT04638920` - Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy
Not yet recruiting	`NCT05897125` - Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.